Showing items 1 - 4 of 4

Depot buprenorphine as an opioid agonist therapy in New South Wales correctional centres: a costing model

- Ling, R., White, B., Roberts, J., Cretikos, M., Howard, M. V., Haber, P. S., Lintzeris, N., Reeves, P., Dunlop, A. J., Searles, A.

Alcohol text messages: a developmental study

- Robinson, Maryanne, Wilkinson, R. B., Fletcher, R., Bruno, R., Baker, A. L., Maher, L., Wroe, J., Dunlop, A. J.

Effect of treatment willingness on specialist assessment and treatment uptake for hepatitis C virus infection among people who use drugs: The ETHOS study

- Alavi, M., Micallef, M., Grebely, J., Fortier, E., Dunlop, A. J., Balcomb, A. C., Day, C. A., Treloar, C., Bath, N., Haber, P. S., Dore, G. J.

A randomised controlled trial of sublingual buprenorphine-naloxone film versus tablets in the management of opioid dependence

- Lintzeris, N., Leung, S. Y., Ali, R., Dunlop, A. J., Larance, B., White, N., Rivas, G. R., Holland, R. M., Degenhardt, L., Muhleisen, P., Hurley, M.

  • 1
  • Disclaimer
  • Privacy
  • Copyright
  • Contact
  • Deposit